Hl. Perez et al., Simultaneous analysis of hemoglobin adducts of acrylamide and glycidamide by gas chromatography-mass spectrometry, ANALYT BIOC, 274(1), 1999, pp. 59-68
Acrylamide (AA) is a carcinogen in experimental animals. Glycidamide (GA),
formed by metabolic epoxidation of AA, is believed to be responsible for th
e carcinogenicity of AA. Occupational exposure to AA has been assessed earl
ier by measurement of its adducts with N-terminal valine in hemoglobin. A b
ackground of AA adducts [N-(2-carbamoylethyl) valine (AAVal), about 30 pmol
/g globin] was found in individuals without known exposure to the compound.
The method previously available for adducts of GA only allowed analysis of
samples from highly exposed individuals and showed similar levels of AAVal
and adducts of GA [N-(2-hydroxy-2-carbamoylethyl)valine (GAVal)]. We have
developed a sensitive method for simultaneous quantification of adducts of
GA and AA, which is suitable down to low exposure levels. The method is bas
ed on the so-called modified Edman method, where globin is reacted with pen
tafluorophenyl isothiocyanate under neutral conditions, The valine adducts
are then extracted in the form of pentafluorophenylthiohydantoin (PFPTH) de
rivatives, The analytical procedure included reaction of the PFPTH derivati
ves with acetic anhydride in order to protect the hydroxyl group of GAVal,
The PFPTH derivatives of AAVal and GAVal were analyzed by gas chromatograph
y/tandem mass spectrometry, (H-2(2))AAVal-PFPTH was used as the internal st
andard. The method was applied to samples from 11 workers at an AA producti
on plant, 1 nonexposed nonsmoker, and a few participants of a smoking cessa
tion program. AAVal levels were in the range 27-1854 pmol/g globin, Recorde
d levels of GAVal were 3-12% of those of AAVal, suggesting that previous me
asurements of GAVal overestimate GAVal at low levels Of exposure to AA. (C)
1999 Academic Press.